SXTC_OUT_1 [2025-04-28 04:07:14 -0400] 6401 Bytes | 1702 tokens | Cum: 1702 tkns (21.27% of 8k)
==========================================================================

Listen up, partner—it's 4:07 AM on Mon Apr 28, 2025, and I’m revved up about China SXT Pharmaceuticals (SXTC), climbing from $2.29 to $2.43. This stock is buzzing big-time—do we have a hidden gem, or a flash in the pan? Help me sift through the data!

--- COMPANY PROFILE ---
Company: China SXT Pharmaceuticals (SXTC)
IPO: 2019-01-04 (6 Years Ago)
Market Cap: $38,124,252
Shares Outstanding: 13,760,000
Exchange: XNAS
Description: China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

Here’s a list of headlines for China SXT Pharmaceuticals:

Mar-17-25 08:30AM - China SXT Pharmaceuticals Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency
Feb-21-25 12:35PM - China SXT Pharmaceuticals, Inc. Announces Share Consolidation
Oct-07-24 04:15PM - China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
Oct-26-23 04:05PM - China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq's Minimum Bid Price Rule
Oct-04-23 08:30AM - China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split
Aug-02-23 06:03AM - China SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022)
May-10-23 08:00AM - China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule
Mar-29-23 09:43AM - Insiders who placed huge bets on China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) earlier this year would be disappointed with the 12% drop
Nov-07-22 08:00AM - China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
May-18-22 12:30PM - China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split
Mar-14-22 10:33PM - China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million
Jan-20-22 12:30PM - Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC).
Jan-20-22 12:30PM 10:45AM - China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment
Jan-18-22 07:46AM - China SXT Pharmaceuticals Shares Plunge On $3.5M Equity Raise Issued At Steep Discount
Jan-18-22 07:46AM 06:47AM - China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares
Jan-14-22 05:43PM - China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares
Jan-14-22 05:43PM 02:00PM - China SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of Luxuejin
Dec-16-21 08:00AM - China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
Oct-18-21 08:00AM - China SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-Inspection
Feb-19-21 08:00AM - China SXT Pharmaceuticals, Inc. Announces 1 for 4 Reverse Share Split
Nov-26-20 08:16PM - Is China SXT Pharmaceuticals, Inc. (SXTC) A Good Stock To Buy?
Sep-09-20 09:00AM - NASDAQ Granted China SXT Pharmaceuticals, Inc. 180-Day Extension to Regain Compliance with Bid Price Requirement

Prior AI Reports for SXTC:
1. 2025-04-17 – Score: 15 – Target: 0.8500 – Highs: 2.4500 / 2.0500 / 3.22
china-sxt-pharmaceuticals-faces-steep-declines-amid-market-challenges

(Note: Highs = Same day / 2nd day / 3rd day)

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2025-02-21T17:35:00Z - China SXT Pharmaceuticals, Inc. Announces Share Consolidation
B2 - 2024-07-12T09:35:41Z - Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
B3 - 2024-04-17T17:36:19Z - Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
B4 - 2024-04-17T10:13:57Z - Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
B5 - 2024-04-16T18:17:57Z - Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B6 - 2024-01-02T18:35:24Z - Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for China SXT Pharmaceuticals (SXTC).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

SXTC_OUT_3 [2025-04-28 04:07:14 -0400] 787 Bytes | 218 tokens | Cum: 1922 tkns (24.02% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**China SXT Pharmaceuticals, Inc. Announces Share Consolidation**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/02/21/3030608/0/en/China-SXT-Pharmaceuticals-Inc-Announces-Share-Consolidation.htmlChina SXT Pharmaceuticals, Inc. (SXTC) announced a 1-for-8 share consolidation to regain compliance with the Nasdaq's minimum bid price requirement of $1.00 per share. The company's shares will begin trading on a post-consolidation basis on February 25, 2025.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

SXTC_OUT_5 [2025-04-28 04:07:15 -0400] 1003 Bytes | 300 tokens | Cum: 2224 tkns (27.80% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-25T17:06:15Z - 12 Health Care Stocks Moving In Friday's Intraday Session - Coeptis Therapeutics (NASDAQ:COEP), Cycl...
A2 - 2025-04-24T20:32:59Z - Promising Small Cap Stocks To Add to Your Watchlist - April 22nd...
A3 - 2025-04-23T17:05:58Z - 12 Health Care Stocks Moving In Wednesday's Intraday Session - Artelo Biosciences (NASDAQ:ARTL), Ens...
A4 - 2025-04-23T11:01:37Z - Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - AgriFORC...
A5 - 2025-04-22T21:05:48Z - 12 Health Care Stocks Moving In Tuesday's After-Market Session - Akari Therapeutics (NASDAQ:AKTX), G...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

SXTC_OUT_7 [2025-04-28 04:07:16 -0400] 1181 Bytes | 351 tokens | Cum: 2577 tkns (32.21% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Friday's Intraday Session - Coeptis Therapeutics (NASDAQ:COEP), Cyclacel Pharmaceuticals (NASDAQ:CYCC)**Date: 2025-04-25Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/04/45015979/12-health-care-stocks-moving-in-fridays-intraday-sessionGainers Jaguar Health JAGX stock increased by 61.0% to $12.98 during Friday's regular session. The company's market cap stands at $8.7 million. China SXT Pharmaceuticals SXTC shares increased by 42.96% to $2.26. The company's market cap stands at $31.0 million. Cyclacel Pharmaceuticals CYCC shares rose 23.66% to $0.28. The market value of their outstanding shares is at $3.9 million. Vicarious Surgical RBOT stock rose 15.48% to $7.68. The market value of their outstanding shares is at $45.5 million. ENDRA Life Sciences NDRA stock rose 15.06% to $3.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

SXTC_OUT_9 [2025-04-28 04:07:19 -0400] 1181 Bytes | 359 tokens | Cum: 2938 tkns (36.73% of 8k)
==========================================================================

Showing A1 (chunk 2 of 3): 97. The company's market cap stands at $2.1 million. Psyence Biomedical PBM stock rose 14.45% to $0.53. The market value of their outstanding shares is at $2.3 million. Losers Coeptis Therapeutics COEP shares declined by 36.9% to $7.86 during Friday's regular session. The company's market cap stands at $25.4 million. Summit Therapeutics SMMT stock fell 36.76% to $23.21. The company's market cap stands at $17.1 billion. Intensity Therapeutics INTS shares fell 33.66% to $0.6. The company's market cap stands at $9.0 million. VYNE Therapeutics VYNE stock declined by 23.75% to $1.43. The company's market cap stands at $21.1 million. Sutro Biopharma STRO stock decreased by 21.4% to $1.02. The company's market cap stands at $85.6 million. Instil Bio TIL stock declined by 21.1% to $15.47. The market value of their outstanding shares is at $101.4 million. See Also: www.benzinga.com/money/best-hea

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

SXTC_OUT_11 [2025-04-28 04:07:20 -0400] 1084 Bytes | 353 tokens | Cum: 3293 tkns (41.16% of 8k)
==========================================================================

Showing A1 (chunk 3 of 3): lthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

COEPCoeptis Therapeutics Holdings Inc$7.95-36.3%Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock - anytime.

Reveal Full ScoreEdge RankingsMomentum98.58Price TrendShortMediumLongOverviewCYCCCyclacel Pharmaceuticals Inc$0.23000.44%INTSIntensity Therapeutics Inc$0.5715-36.5%JAGXJaguar Health Inc$11.6444.4%NDRAENDRA Life Sciences Inc$3.9414.2%PBMPsyence Biomedical Ltd$0.516912.4%RBOTVicarious Surgical Inc$7.6815.5%SMMTSummit Therapeutics Inc$23.21-36.8%STROSutro Biopharma Inc$1.02-21.1%SXTCChina SXT Pharmaceuticals Inc$2.2039.2%TILInstil Bio Inc$15.06-23.2%VYNEVYNE Therapeutics Inc$1.46-22.3%Market News and Data brought to you by Benzinga APIs

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

SXTC_OUT_13 [2025-04-28 04:07:22 -0400] 238 Bytes | 59 tokens | Cum: 3354 tkns (41.93% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

SXTC_OUT_15 [2025-04-28 04:07:22 -0400] 251 Bytes | 78 tokens | Cum: 3435 tkns (42.94% of 8k)
==========================================================================

You just read a chunk of S1.
You may now:
- Say "MOR" to continue this article
- Say "S2", "S3", etc. to request another
- Or say "NEX" to move to the next source

You are allowed up to 6 articles from this list. If you’re ready to move on, say NEX.

SXTC_OUT_17 [2025-04-28 04:07:30 -0400] 4983 Bytes | 1185 tokens | Cum: 4623 tkns (57.79% of 8k)
==========================================================================

This is our set of metrics for China SXT Pharmaceuticals.
Please analyze the numbers.

+--------------------+-----------------------+------------------------+----------------------+
| Volume: 38,013,524 | Perf Month: -17.33% | Option/Short: No / No | Sales Y/Y TTM: 6.78% |
+--------------------+-----------------------+------------------------+----------------------+
| Avg Volume: 3.48M | Perf Quarter: -33.74% | Short Float: 0.37% | ROE: 57.63% |
+--------------------+-----------------------+------------------------+----------------------+
| Rel Volume: 12.99 | Index: - | Short Ratio: 0.01 | ROI: 37.79% |
+--------------------+-----------------------+------------------------+----------------------+
| RSI (14): 49.50 | Market Cap: 31.52M | Short Interest: 0.05M | Sales Surprise: - |
+--------------------+-----------------------+------------------------+----------------------+
| ATR (14): 0.68 | Shs Outstand: 13.76M | Beta: 1.25 | EPS Surprise: - |
+--------------------+-----------------------+------------------------+----------------------+
| SMA20: 3.15% | Shs Float: 13.73M | Sales Q/Q: - | P/E: 0.84 |
+--------------------+-----------------------+------------------------+----------------------+
| SMA50: -24.19% | Inst Own: 0.01% | Sales past 5Y: -19.85% | Earnings: - |
+--------------------+-----------------------+------------------------+----------------------+
| SMA200: -49.69% | Insider Own: 0.27% | Employees: 75 | |
+--------------------+-----------------------+------------------------+----------------------+
| Perf Week: 6.02% | Insider Trans: 0.00% | Debt/Eq: 0.16 | |
+--------------------+-----------------------+------------------------+----------------------+

The next section covers any insider trading by China SXT Pharmaceuticals officers or majority shareholders (if available).

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 2.29
Average Volume: 11161092.58
30-Day High: 2.86
30-Day Low: 0.9889
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of China SXT Pharmaceuticals (SXTC).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about China SXT Pharmaceuticals.

2) MARKET_SCORE[]
This conversation was initiated because SXTC is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for SXTC.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, SXTC could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect SXTC to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of China SXT Pharmaceuticals.

11) ETHICAL_RATING[]
Rate China SXT Pharmaceuticals’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of China SXT Pharmaceuticals.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

SXTC_IN_19 [2025-04-28 04:07:31 -0400] 126 Bytes | 29 tokens | Cum: 4898 tkns (61.22% of 8k)
==========================================================================

====================================
[2025-04-28 04:07:31] # Analysis Completed
Elapsed Time: 18.29 seconds